| Mon, Nov 23, 2009 | | • | Biotech Stocks: Europe drug stocks rally; Cephalon slides
at MarketWatch (Mon, Nov 23)
| | Thu, Nov 19, 2009 | | • | UK health unit rejects Bayer drug as too expensive
at MarketWatch (Thu, Nov 19)
| | Tue, Nov 17, 2009 | | • | Oculus Wins China Approval for Animal Wound Product
at Seeking Alpha (Tue, Nov 17)
| | Thu, Nov 12, 2009 | | • | Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
GlobeNewswire (Thu, Nov 12)
| | Mon, Nov 2, 2009 | | • | CEO Interview: Aeolus Pharmaceuticals, Inc. - John L. McManus
Wall Street Transcript (Mon, Nov 2)
| | • | The World's Top Chemical Companies
at Seeking Alpha (Mon, Nov 2)
| | Wed, Oct 28, 2009 | | • | Bayer Disappoints
Zacks.com (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | • | Bayer Earnings Call scheduled for 10:00 am ET today
CCBN (Tue, Oct 27)
| | • | Q3 2009 Bayer Earnings Release - 02:30 am ET
CCBN (Tue, Oct 27)
| | Fri, Oct 16, 2009 | | • | Buzzed Off At Bayer
at Forbes.com (Fri, Oct 16)
| | Thu, Oct 8, 2009 | | • | OncoGenex: Room for Further Growth?
at Seeking Alpha (Thu, Oct 8)
| | Mon, Oct 5, 2009 | | • | Syngenta upgraded to outperform at Credit Suisse
at MarketWatch (Mon, Oct 5)
| | Wed, Sep 30, 2009 | | • | Bayer downgraded to neutral from buy at UBS
at MarketWatch (Wed, Sep 30)
| | • | Bayer, Onyx report progress on breast-cancer drug
at MarketWatch (Wed, Sep 30)
| | Thu, Sep 17, 2009 | | • | Stocks: Quality Still Counts
at BusinessWeek (Thu, Sep 17)
| | Tue, Sep 15, 2009 | | • | Biotech Stocks: Drug stocks mixed; BioCryst gains
at MarketWatch (Tue, Sep 15)
| | • | Biotech Stocks: Drug stocks trend lower; BioCryst gains
at MarketWatch (Tue, Sep 15)
| | Tue, Sep 1, 2009 | | • | Monsanto Backs French Biotech Firm
at Forbes.com (Tue, Sep 1)
| | Mon, Aug 3, 2009 | | • | Roche's Avastin approved to treat kidney cancer
at MarketWatch (Mon, Aug 3)
| | Wed, Jul 29, 2009 | | • | Bayer Earnings Call scheduled for 8:00 am ET today
CCBN (Wed, Jul 29)
|
Add BAYRY.PK News to My Yahoo!:
 
| |
|
0.34% Nasdaq 0.00%
Headlines
